Your search returned 3 results.

Results
	1.	Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. [electronic resource] by Reuther, Clemens Heinzle, Vera Spampatti, Matilde Vlotides, George de Toni, Enrico Spöttl, Gerald Maurer, Julian Nölting, Svenja Göke, Burkhard Auernhammer, Christoph J Producer: 20170515 In: Neuroendocrinology vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. [electronic resource] by Reuther, Clemens Heinzle, Vera Nölting, Svenja Herterich, Sabine Hahner, Stefanie Halilovic, Ensar Jeay, Sébastien Wuerthner, Jens U Aristizabal Prada, Elke Tatjana Spöttl, Gerald Maurer, Julian Auernhammer, Christoph J Producer: 20190103 In: Neuroendocrinology vol. 106 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors. [electronic resource] by Aristizabal Prada, Elke Tatjana Heinzle, Vera Knösel, Thomas Nölting, Svenja Spöttl, Gerald Maurer, Julian Spitzweg, Christine Angele, Martin Schmidt, Nina Beuschlein, Felix Stalla, Günter K Blaser, Rainer Kuhn, Klaus A Auernhammer, Christoph J Producer: 20190417 In: Endocrine-related cancer vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)